Ubs Group Ag Novo Nordisk A S Transaction History
Ubs Group Ag
- $528 Billion
- Q1 2025
A detailed history of Ubs Group Ag transactions in Novo Nordisk A S stock. As of the latest transaction made, Ubs Group Ag holds 1,433,026 shares of NVO stock, worth $94.8 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,433,026
Previous 124,718
1049.01%
Holding current value
$94.8 Million
Previous $10.7 Million
827.56%
% of portfolio
0.02%
Previous 0.0%
Shares
33 transactions
Others Institutions Holding NVO
# of Institutions
1,763Shares Held
328MCall Options Held
10.8MPut Options Held
14.5M-
Jennison Associates LLC18.8MShares$1.25 Billion0.93% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$979 Million0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$819 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$815 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$785 Million0.36% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $149B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...